CRYSTALLINE CIS-(E)-4-(3-FLUOROPHENYL)-2,3,4,9-TETRAHYDRO-N,N- DIMETHYL-2- (1-OXO-3-PHENYL-2-PROPENYL)-SPIRO[CYCLOHEXANE-1 ,1[1H]- PYRIDO[3,4-B]INDOL]-4-AMINE -(E)-4-(3-)-2349--NN--2-(1- -3--2-)-[-11[1H]-[34-B]]-4-

摘要

The present invention relates to crystalline forms of cis-(E)-4-(3-Fluorophenyl)-2′,3′,4′,9′-tetrahydro-N,N-dimethyl-2′-(1-oxo-3-phenyl-2-propenyl)-spiro[cyclohexane-1,1′[1H]-pyrido[3,4-b]indol]-4-amine, pharmaceutical compositions and medicaments comprising these modifications, the use of these modifications as well as to a process for making the crystalline forms.